Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.827,95
1,49%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Oncolytics Biotech Inc (ONCY) Oncolytics Biotech Inc (ONCY) Notizie

ONCY

Oncolytics Biotech (ONCY)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ONCY
DataOraFonteTitoloSimboloCompagnia
07/03/202422:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
26/09/202314:00PR Newswire (US)THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTSNASDAQ:ONCYOncolytics Biotech Inc
22/06/202315:23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
03/03/202317:24Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ONCYOncolytics Biotech Inc
09/12/202218:25TipRanksOncolytics Biotech (ONCY) Receives a Buy from Maxim GroupNASDAQ:ONCYOncolytics Biotech Inc
02/12/202218:25TipRanksMaxim Group Sticks to Its Buy Rating for Oncolytics Biotech (ONCY)NASDAQ:ONCYOncolytics Biotech Inc
23/11/202212:30TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:ONCYOncolytics Biotech Inc
22/11/202218:15TipRanksMaxim Group Reaffirms Their Buy Rating on Oncolytics Biotech (ONCY)NASDAQ:ONCYOncolytics Biotech Inc
18/08/202212:15TipRanksH.C. Wainwright Remains a Buy on Oncolytics Biotech (ONCY)NASDAQ:ONCYOncolytics Biotech Inc
15/07/202212:15TipRanksH.C. Wainwright Thinks Oncolytics Biotech’s Stock is Going to RecoverNASDAQ:ONCYOncolytics Biotech Inc
16/06/202222:22Edgar (US Regulatory)Amended Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10/a)NASDAQ:ONCYOncolytics Biotech Inc
10/06/202223:14Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:ONCYOncolytics Biotech Inc
10/06/202212:01Edgar (US Regulatory)Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10)NASDAQ:ONCYOncolytics Biotech Inc
11/04/202212:15TipRanksAnalysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY), Stealth Biotherapeutics (MITO) and Genocea Biosciences (GNCA)NASDAQ:ONCYOncolytics Biotech Inc
07/03/202212:25TipRanksAnalysts’ Top Healthcare Picks: Check-Cap (CHEK), Axsome Therapeutics (AXSM)NASDAQ:ONCYOncolytics Biotech Inc
05/03/202217:05TipRanksLeede Jones Gable Thinks Oncolytics Biotech’s Stock is Going to RecoverNASDAQ:ONCYOncolytics Biotech Inc
10/01/202217:57PR Newswire (US)New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024NASDAQ:ONCYOncolytics Biotech Inc
05/03/202123:08Edgar (US Regulatory)Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl)NASDAQ:ONCYOncolytics Biotech Inc
26/08/202016:15Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ONCYOncolytics Biotech Inc
16/06/202012:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ONCYOncolytics Biotech Inc
12/12/201813:00GlobeNewswire Inc.Oncolytics Biotech® Announces First Patient Treated in Study Combining Pelareorep, Carfilzomib and the Checkpoint Inhibitor ...NASDAQ:ONCYOncolytics Biotech Inc
03/12/201813:00GlobeNewswire Inc.Oncolytics Biotech® Announces Increased PD-L1 Expression When Combining Pelareorep with a Proteasome Inhibitor in Poster Pr...NASDAQ:ONCYOncolytics Biotech Inc
29/11/201813:00GlobeNewswire Inc.Oncolytics Biotech® Announces Appointment of Rita Laeufle, M.D., as Chief Medical OfficerNASDAQ:ONCYOncolytics Biotech Inc
26/11/201814:00GlobeNewswire Inc.Oncolytics Biotech® Announces First Patient Treated in Phase 2 Study Combining Pelareorep and Keytruda® in Advanced Pancrea...NASDAQ:ONCYOncolytics Biotech Inc
13/11/201813:00GlobeNewswire Inc.Oncolytics Biotech® Announces Attendance of Upcoming ConferencesNASDAQ:ONCYOncolytics Biotech Inc
12/11/201813:00GlobeNewswire Inc.Oncolytics Biotech® Reports 2018 Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:ONCYOncolytics Biotech Inc
09/11/201813:00GlobeNewswire Inc.Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Meeting Showcasing Upregul...NASDAQ:ONCYOncolytics Biotech Inc
05/11/201813:00GlobeNewswire Inc.Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Corporate HighlightsNASDAQ:ONCYOncolytics Biotech Inc
01/11/201812:00GlobeNewswire Inc.Oncolytics Biotech® Announces Abstract for ASH Annual Meeting & Exposition Demonstrating Pelareorep Increases PD-L1 Expressi...NASDAQ:ONCYOncolytics Biotech Inc
25/10/201802:25GlobeNewswire Inc.Oncolytics Biotech® Establishes New At-The-Market FacilityNASDAQ:ONCYOncolytics Biotech Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ONCY

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network